Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Vascular endothelial growth factor in Coats' disease.
[coats disease]
To
examine
whether
vascular
endothelial
growth
factor
(
VEGF
)
as
one
of
the
most
important
intraocular
cytokines
for
angiogenesis
and
increased
vascular
permeability
is
associated
with
Coats
'
disease
.
The
clinical
interventional
study
included
28
patients
with
Coats
'
disease
and
seven
control
patients
with
congenital
cataract
.
During
intraocular
surgery
,
we
obtained
aqueous
humour
samples
in
which
the
VEGF
concentration
was
measured
by
double
-antibody
sandwich
enzyme-linked
immunosorbent
assay
(
ELISA
)
.
Coats
'
disease
was
graded
into
four
stages
.
The
mean
aqueous
VEGF
level
was
significantly
higher
in
the
Coats
'
study
group
than
in
the
control
group
(
158
±
88
versus
97
±
21
pg
/
ml
;
p
=
0
.
002
)
.
The
VEGF
concentrations
increased
significantly
(
p
<
0
.
001
)
from
91
±
32
pg
/
ml
in
Coats
'
disease
stage
2
to
100
±
37
pg
/
ml
in
stage
3
A
1
,
185
±
56
pg
/
ml
in
stage
3
A
2
to
256
±
93
pg
/
ml
in
patients
with
stage
3
B
.
Vascular
endothelial
growth
factor
concentrations
in
Coats
'
stage
2
and
3
A
1
did
not
differ
significantly
from
the
values
in
the
control
group
.
Parallel
to
the
association
with
the
stage
of
the
diseases
,
the
VEGF
concentrations
were
significantly
(
p
<
0
.
001
)
correlated
with
extent
of
exudative
retinal
detachment
.
Increasing
severity
of
Coats
'
disease
is
significantly
associated
with
intraocular
VEGF
concentrations
.
These
results
favour
the
intravitreal
application
of
anti-
VEGF
drugs
as
medical
therapy
of
Coats
'
diseases
.
Diseases
Validation
Diseases presenting
"growth factor"
symptom
22q11.2 deletion syndrome
achondroplasia
adrenal incidentaloma
aniridia
cadasil
cholangiocarcinoma
coats disease
dedifferentiated liposarcoma
dentin dysplasia
dentinogenesis imperfecta
dystrophic epidermolysis bullosa
esophageal carcinoma
esophageal squamous cell carcinoma
hodgkin lymphoma, classical
holt-oram syndrome
inclusion body myositis
kallmann syndrome
krabbe disease
liposarcoma
lymphangioleiomyomatosis
oculocutaneous albinism
oral submucous fibrosis
pleomorphic liposarcoma
primary effusion lymphoma
primary hyperoxaluria type 1
severe combined immunodeficiency
systemic capillary leak syndrome
von hippel-lindau disease
wolf-hirschhorn syndrome
x-linked adrenoleukodystrophy
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom